Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
The 2021 STEP trial, a multicenter randomized controlled study, investigated the impact of intensive versus standard systolic blood pressure (SBP) control in 8,511 hypertensive patients aged 60–80 in China. Participants were randomized to either an intensive-treatment group (target SBP 110–